Zogenix, Inc. (NASDAQ:ZGNX) has a beta value of 1.78 and has seen 2,727,081 shares traded in the last trading session. The company, currently valued at $1.45 Billion, closed the last trade at $26.11 per share which meant it gained $0.6 on the day or 2.51% during that session. The ZGNX stock price is -119.15% off its 52-week high price of $57.22 and 36.23% above the 52-week low of $16.65. If we look at the company’s 10-day average daily trading volume, we find that it stood at 3.54 Million shares traded. The 3-month trading volume is 989.12 Million shares.
The consensus among analysts is that Zogenix, Inc. (ZGNX) is a Buy stock at the moment, with a recommendation rating of 1.7. None of the analysts rate the stock as a Sell, while none rate it as Overweight. 2 out of 12 have rated it as a Hold, with 10 advising it as a Buy. None have rated the stock as Underweight. The expected earnings per share for the stock is -$1.
Zogenix, Inc. (NASDAQ:ZGNX) trade information
Sporting 2.51% in the green today, the stock has traded in the green over the last five days, with the highest price hit on Friday, Jun 26 when the ZGNX stock price touched $32.42- or saw a rise of 19.46%. Year-to-date, Zogenix, Inc. shares have moved -49.91%, while the 5-day performance has seen it change -8.42%. Over the past 30 days, the shares of Zogenix, Inc. (NASDAQ:ZGNX) have changed -10.37%. Short interest in the company has seen 7.25 Million shares shorted with days to cover at 0.01.
Wall Street analysts have a consensus price target for the stock at $49.33, which means that the shares’ value could jump 88.93% from current levels. The projected low price target is $26 while the price target rests at a high of $69. In that case, then, we find that the current price level is +164.27% off the targeted high while a plunge would see the stock lose -0.42% from current levels.
Zogenix, Inc. (ZGNX) estimates and forecasts
Figures show that Zogenix, Inc. shares have underperformed across the wider relevant industry. The company’s shares have lost -49.42% over the past 6 months, with this year growth rate of -67.35%, compared to 12.4% for the industry. Other than that, the company has, however, lowered its growth outlook for the 2020 fiscal year revenue. Growth estimates for the current quarter are -12.4% and 86.7% for the next quarter. Revenue growth from the last financial year stood is estimated to be +359.4%.
10 analysts offering their estimates for the company have set an average revenue estimate of $540Million for the current quarter. 10 have an estimated revenue figure of $3.84 Million for the next quarter concluding in September 01, 2020. Year-ago sales stood $1.07 Million and $630Million respectively for this quarter and the next, and analysts expect sales will grow by -49.5% for the current quarter and 509.5% for the next.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -37% over the past 5 years. Earnings growth for 2020 is a modest -198.2% while over the next 5 years, the company’s earnings are expected to increase by 8.8%.